New York, January 5, 2026, 18:14 (EST) — After-hours
- Rocket Lab shares closed up 2.8% at $78.15 and slipped 0.7% in after-hours trading.
- Cantor Fitzgerald reiterated an Overweight rating and a $72 price target, according to Investing.com.
- Investors are watching Rocket Lab’s Jan. 13–14 appearance at Needham’s Growth Conference for updates on SDA execution and Neutron timing.
Rocket Lab Corp (RKLB.O) shares rose 2.8% in regular trading on Monday to $78.15, then dipped about 0.7% after hours.
The move keeps the space company’s stock near a 52-week high after a sharp late-December run, with investors weighing whether Rocket Lab can deliver on a growing pipeline of U.S. national security satellite work while it develops its next rocket.
Cantor Fitzgerald reiterated an Overweight rating — meaning the firm expects the stock to outperform peers over time — and kept a $72 price target, according to Investing.com. The stock closed above that target, underscoring how stretched valuations have become after the recent surge.
Rocket Lab’s recent rally has been tied to a defense win announced in December: the company said it was awarded an $816 million prime contract to design and manufacture 18 satellites for the Space Development Agency’s Tracking Layer Tranche 3 program. A prime contractor leads the project and is responsible for delivery.
The Space Development Agency, part of the U.S. Space Force, said it placed about $3.5 billion in fixed-price satellite orders across Rocket Lab and three large defense contractors — Lockheed Martin (LMT.N), Northrop Grumman (NOC.N) and L3Harris Technologies (LHX.N) — with 18 satellites apiece. Fixed-price deals typically put cost overruns on the contractor.
Rocket Lab said its tranche-3 satellites will carry its Phoenix infrared sensor payload and StarLite protection sensors, and that additional subsystem opportunities could lift the total capture value to about $1 billion. CEO Peter Beck said: “Rocket Lab is honored to play a role in enabling this.” Rocket Lab
Monday’s session was volatile, with the stock trading between $71.31 and $78.25. About 33.4 million shares changed hands, versus roughly 31.2 million on the prior session, based on published historical data.
The key debate for investors is timing: the SDA tranche-3 satellites are expected to be launched into low Earth orbit in 2029, the agency has said, while Rocket Lab’s planned Neutron rocket — aimed at larger payloads than its Electron vehicle — is the nearer-term event risk that could shape 2026 sentiment.
But the downside case is straightforward. A slip in Neutron’s schedule, execution stumbles on large fixed-price work, or slower option capture than investors expect could pressure a stock already trading near its 52-week peak.
Next up, traders will focus on Rocket Lab’s Jan. 13–14 slot at Needham’s Growth Conference for any fresh color on tranche execution, production ramp and Neutron milestones.
